Richwood Investment Advisors, LLC Biogen Inc. Transaction History

Richwood Investment Advisors, LLC

$121 Million
Q3 2024

A detailed history of Richwood Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Richwood Investment Advisors, LLC holds 3,432 shares of BIIB stock, worth $515,452. This represents 0.55% of its overall portfolio holdings.

Number of Shares

3,432

Previous 3,854 10.95%

Holding current value

$515,452

Previous $893,000 25.53%

% of portfolio

0.55%

Previous 0.78%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$189.07 - $236.8 $79,787 - $99,929	-422 Reduced 10.95%	3,432 $665,000
Q2 2024 Jul 26, 2024	SELL	$190.52 - $236.72 $381 - $473	-2 Reduced 0.05%	3,854 $893,000
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $9,328 - $11,779	-44 Reduced 1.13%	3,856 $831,000
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $23,817 - $28,669	-107 Reduced 2.67%	3,900 $1.01 Million
Q3 2023 Oct 30, 2023	SELL	$253.3 - $285.89 $36,728 - $41,454	-145 Reduced 3.49%	4,007 $1.03 Million
Q2 2023 Jul 21, 2023	SELL	$275.25 - $318.06 $24,497 - $28,307	-89 Reduced 2.1%	4,152 $1.18 Million
Q1 2023 Apr 19, 2023	SELL	$256.56 - $292.34 $145,726 - $166,049	-568 Reduced 11.81%	4,241 $1.18 Million
Q4 2022 Feb 08, 2023	SELL	$252.44 - $306.72 $23,729 - $28,831	-94 Reduced 1.92%	4,809 $1.33 Million
Q3 2022 Oct 27, 2022	SELL	$194.69 - $268.46 $79,628 - $109,800	-409 Reduced 7.7%	4,903 $1.31 Million
Q2 2022 Jul 22, 2022	BUY	$187.54 - $223.02 $15,940 - $18,956	85 Added 1.63%	5,312 $1.08 Million
Q1 2022 Apr 28, 2022	SELL	$193.77 - $244.14 $11,432 - $14,404	-59 Reduced 1.12%	5,227 $1.1 Million
Q4 2021 Feb 17, 2022	BUY	$223.92 - $287.77 $1.18 Million - $1.52 Million	5,286 New	5,286 $1.27 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Richwood Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richwood Investment Advisors, LLC with notifications on news.

Account

Richwood Investment Advisors, LLC Biogen Inc. Transaction History